360
Participants
Start Date
December 31, 2011
Primary Completion Date
July 31, 2014
Study Completion Date
May 31, 2015
CA125 guided strategy
Up titration of loop diuretics according to plasma levels of CA125 in the active arm
CA125 guided strategy
Consider statins in all patients in the active arm
CA125 guided strategy
Consider omega-3 polyunsaturated fatty acids in the active arm
CA125 guided strategy
Frequency of monitoring according plasma evolution of CA125 in the active arm.
Standard treatment strategy
All patients should be treated following standard european guidelines regarding angiotensin converting enzyme inhibitors, angiotensin receptor blockers, beta-blockers, aldosterone antagonists, diuretics, ivabradine and other treatments such as (diet, anticoagulants, antiarrhythmics, statins, omega-3 polyunsaturated fatty acids, digoxin, nitrates and vasoactive group).
CA125 guided strategy
All patients should be treated following standard european guidelines regarding angiotensin converting enzyme inhibitors, angiotensin receptor blockers, beta-blockers, ivabradine and other treatments such as (diet, anticoagulants, antiarrhythmics, digoxin, nitrates and vasoactive group).
Hospital Clínico Unbiversitario de Valencia, Valencia
Ministerio de Sanidad, Servicios Sociales e Igualdad
OTHER_GOV
Fundación para la Investigación del Hospital Clínico de Valencia
OTHER